<DOC>
	<DOCNO>NCT00558467</DOCNO>
	<brief_summary>A randomized , double-blind , placebo-controlled , flexible dose study evaluate efficacy safety Pramipexole versus placebo 6 week child ( age 6-17 ) diagnose Tourette Disorder accord DSM IV criterion . The primary efficacy measure Total Tic Score ( TTS ) Yale Global Tic Severity Scale ( YGTSS ) 6 week .</brief_summary>
	<brief_title>Pramipexole Pilot Phase II Study Children Adolescents With Tourette Disorder According DSM-IV Criteria</brief_title>
	<detailed_description />
	<mesh_term>Tourette Syndrome</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Male female patient 617 yr . Written informed consent . Diagnosed Tourette 's Disorder &gt; equal 22 Total Tic Score baseline . Diagnosed Tourette 's Disorder administer Diagnostic Interview Schedule Children . Having least 1 tic/day . Women childbearing age must negative serum pregnancy test screening must use medically accepted contraceptive method . Either newly diagnose patient patient diagnose Tourette 's Disorder safely discontinue treatment . Having body weight &gt; equal 20 kg ( 44 lb ) . Any woman childbearing age positive serum pregnancy test screening . Patients clinically significant renal disease serum creatinine great 1.0 mg/dL screening . Lab result screen : hemoglobin lower limit normal determine clinically significant ; Thyroid Stimulating Hormone ( TSH ) , triiodothyronine ( T3 ) thyroxine ( T4 ) clinically significant ; clinically significant abnormality labs . Other clinically significant metabolicendocrine , hematological , gastrointestinal disease , pulmonary disease would preclude patient participate study . History Schizophrenia psychotic disorder , history mental disorder present Axis I psychiatric disorder accord Diagnostic Statistic Manual Mental Disorders Fourth Edition ( DSMIV ) require medical therapy except patient diagnosis attention deficit hyperactivity disorder ( ADHD ) obsessivecompulsive disorder ( OCD ) therapy . History of/or clinical sign epilepsy seizures fever related seizure early childhood . History of/or clinical sign malignant neoplasm . Allergic response pramipexole . Had previous treatment dopamine agonist pramipexole within 14 day prior baseline visit . Had medical treatment Tourette 's Disorder besides study medication within 28 day prior baseline visit . Had withdrawal symptom medication screen baseline visit . Having Kaufman Brief Intelligence Test ( KBIT IQ ) score &lt; 70 screening . Having child 's YaleBrown obsessivecompulsive scale ( CYBOCS ) score &gt; 15 baseline . Patients meet criterion Restless Legs Syndrome Periodic Limb Movement disorder . Patients severe asthma . Patients initiated psychotherapy Tourette 's Disorder , OCD ADHD within 3 mths start trial . Patients receive psychological , cognitive and/or behavioral treatment great 3 mths prior start trial Tourette 's Disorder , OCD , and/or ADHD change treatment plan .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>